Peijia Medical Ltd. (HK:9996) has released an update.
Peijia Medical Limited has announced the expected receipt of an initial payment of around $13.10 million from the sale of its minority interest in JenaValve, with potential additional contingent consideration of up to $8.40 million based on the achievement of specific regulatory and performance milestones. The announcement confirms and supplements previous information disclosed on July 26, 2024.
For further insights into HK:9996 stock, check out TipRanks’ Stock Analysis page.
